Potentiation of Chemotherapy in Companion Animals with Spontaneous Large Neoplasms by Application of Biphasic Electric Pulses

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4, 2003, Pages 571-580

  Spugnini, Enrico P ^a   Porrello, A ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Animal models; Bleomycin; Electric pulses; Electrochemotherapy; Neoplasms; Pets

Indexed keywords

BLEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPHASIC ELECTRIC PULSE; CALIPER ELECTRODE; CANCER CHEMOTHERAPY; CATABOLISM; CLINICAL PROTOCOL; CONTROLLED STUDY; DOG; DOMESTIC ANIMAL; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG TOXICITY; ELECTRIC FIELD; ELECTROCHEMOTHERAPY; ELECTRODE; ELECTROSTIMULATION; MOUTH TUMOR; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RABBIT; REMISSION; SKIN TUMOR; SOFT TISSUE CANCER; SOFT TISSUE TUMOR; VASCULITIS;

ANIMALS; ANIMALS, DOMESTIC; BLEOMYCIN; CATS; DOGS; ELECTRIC STIMULATION THERAPY; FEMALE; MALE; NEOPLASMS; RABBITS;

EID: 1242314664     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Strohbehn J.W.: Hyperthermia equipment evaluation. Int. J. Hyperthermia 10: 429-432, 1994.
2. Gabriele P., Orecchia R., Madon E., Ruo Redda M.G., Sannazzari G.L.: The cost of hyperthermia: nine years experience at the Radiation Therapy Department of the Turin University. Tumori 80: 327-331, 1994.
3. Robinson E., Neugut A.I., Wylie P.: Clinical aspects of postirradiation sarcomas. J. Natl. Cancer Inst. 80: 233-240, 1988.
4. Hellman S.: Principles of cancer management: radiation therapy. In: De Vita V.T. Cancer. Principles & Practice of Oncology. 6th Edition. Philadelphia, Lippincott, 2001: 265-288.
5. Chu E., De Vita V.T.: Principles of cancer management: chemotherapy. In: De Vita V.T. Cancer. Principles & Practice of Oncology. 6th Edition. Philadelphia, Lippincott, 2001: 289-306.
6. Weaver J.C.: Electroporation theory. Concepts and mechanisms. Methods Mol. Biol. 47: 1-26, 1995.
7. Neumann E., Kakorin S., Toensing K.: Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem. Bioenerg. 48: 3-16, 1999.
8. Mir L.M., Orlowski S.: Mechanisms of electrochemotherapy. Adv. Drug Deliv. Rev. 35: 107-118, 1999.
9. Poddevin B., Orlowski S., Belehradek J. Jr., Mir L.M.: Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42(S): 67-75, 1991.
10. Pron G., Belehradek J. Jr., Mir L.M.: Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194: 333-337, 1993.
11. Byrnes R.W., Templin J., Sem D., Lyman S., Petering D.H.: Intracellular DNA strand scission and growth inhibition of Ehrlich ascites tumor cells by bleomycins. Cancer Res. 50: 5275-5286, 1990.
12. Tounekti O., Pron G., Belehradek J. Jr., Mir L.M.: Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53: 5462-5469, 1993.
13. Okino M., Esato K.: The effects of a single high voltage electrical stimulation with an anticancer drug on in vivo growing malignant tumors. Jpn. J. Surg. 20: 197-204, 1990.
14. Mir L.M., Orlowski S., Belehradek J. Jr., Paoletti C.: Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer 27: 68-72, 1991.
15. Belehradek J. Jr., Orlowski S., Poddevin B., Paoletti C., Mir L.M.: Electrochemotherapy of spontaneous mammary tumours in mice. Eur. J. Cancer 27: 73-76, 1991.
16. Sersa G., Cemazar M., Miklavcic D.: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res. 55: 3450-3455, 1995.
17. Heller R., Jaroszeski M., Perrott R., Messina J., Gilbert R.: Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 7: 10-18, 1997.
18. Belehradek M., Domenge C., Luboinski B., Orlowski S., Belehradek J. Jr., Mir L.M.: Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72: 3694-3700, 1993.
19. Rudolf Z., Stabuc B., Cemazar M., Miklavcic D., Vodovnik L., Sersa G.: Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol. Oncol. 29: 229-235, 1995.
20. Heller R.: Treatment of cutaneous nodules using electrochemotherapy. J. Fla. Med. Assoc. 82: 147-150, 1995.
21. Heller R., Jaroszeski M.J., Glass L.F., Messina J.L., Rapaport D.P., DeConti R.C., Fenske N.A., Gilbert R.A., Mir L.M., Reintgen D.S.: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77: 964-971, 1996.
22. Glass L.F., Fenske N.A., Jaroszeski M., Perrott R., Harvey D. T., Reintgen D.S., Heller R.: Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J. Am. Acad. Dermatol. 34: 82-86, 1996.
23. Domenge C., Orlowski S., Luboinski B., De Baere T., Schwaab G., Belehradek J. Jr., Mir L.M.: Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 77: 956-963, 1996.
24. Glass L.F., Pepine M.L., Fenske N.A., Jaroszeski M., Reintgen D.S., Heller R.: Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch. Dermatol. 132: 1353-1357, 1996.
25. Glass L.F., Jaroszeski M., Gilbert R., Reintgen D.S., Heller R.: Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J. Am. Acad. Dermatol. 37: 596-599, 1997.
26. Heller R., Jaroszeski M.J., Reintgen D.S., Puleo C.A., DeConti R.C., Gilbert R.A., Glass L.F.: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83: 148-157, 1998.
27. Hofmann G.A., Dev S.B., Dimmer S., Nanda G.S.: Electroporation therapy: a new approach for the treatment of head and neck cancer. IEEE Trans. Biomed. Eng. 46: 752-759, 1999.
28. Daskalov I., Mudrov N., Peycheva E.: Exploring new instrumentation parameters for electrochemotherapy. Attacking tumors with bursts of biphasic pulses instead of single pulses. IEEE Eng. Med. Biol. Mag. 18: 62-66, 1999.
29. Peycheva E., Daskalov I.: Electrochemotherapy of skin tumors. Journal of BUON 4: 185-188, 1999.
30. Mir L.M., Devauchelle P., Quintin-Colonna F., Delisle F., Doliger S., Fradelizi D., Belehradek J. Jr., Orlowski S.: First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br. J. Canc. 76: 1617-1622, 1997.
31. Tozon N., Sersa G., Cemazar M.: Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res. 21: 2483-2488, 2001.
32. Hahn K.A., Bravo L., Adams W.H., Frazier D.L.: Naturally occurring tumors in dogs as comparative models for cancer therapy research. In vivo 8: 133-143, 1994.
33. Thamm D.H., VaiI D.M.: Mast cell tumors. In: Withrow S.J., Mac Ewen G.E. Small Animal Clinical Oncology. 3rd Edition. Philadelphia, W. B. Saunders Company, 2001: 262-263.
34. Orenberg E.K., Luck E.E., Brown D.M., Kitchell B.E.: Implant delivery system: intralesional delivery of chemotherapeutic agents for treatment of spontaneous skin tumors in veterinary patients. Clin. DermatoI. 9: 561-568, 1991.
35. Theon A.P., Pascoe J.R., Carlson G.P., Krag D.N.: Intratumoral chemotherapy with cisplatin in oily emulsion in horses. J. Am. Vet. Med. Assoc. 202: 261-267, 1993.
36. Theon A.P., Pascoe J.R., Meagher D.M.: Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae. J. Am. Vet. Med. Assoc. 205: 1170-1176, 1994.
37. Kitchell B.K., Orenberg E.K., Brown D.M., Hutson C., Ray K., Woods L., Luck E.: Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma. Eur. J. Cancer 31A: 2093-2098, 1995.
38. James K., Eisenhauer E., Christian M., Terenziani M., Vena D., Muldal A., Therasse P.: Measuring response in solid tumors: unidimensional versus bidimensional measurement. J. Natl. Cancer Inst. 91: 523-528, 1999.
39. Colton T.: Statistics in medicine. Boston, Little, Brown & Co, 1974.
40. Marcus S.L., Eizing A.I.: Acute tumor lysis syndrome: prevention and management. In: Dutcher J.P., Wiernik P.H. (eds). Handbook of hematologic and oncologic emergencies. NY, Plenum Press, 1987: 9-15.
41. Couto C.G.: Management of complications of cancer chemotherapy. Vet. Clin. North Am. Small Anim. Pract. 20: 1037-1053, 1990.
42. Ogilvie G.K., Moore A.S.: Clinical briefing: Acute tumor lysis syndrome. In: Ogilvie G.K., Moore A.S. Managing the veterinary cancer patient. New Jersey, Veterinary leaming systems, 1995: 157-159.
43. Agnelli G.: Venous thromboembolism and cancer: a two-way clinical association. Thromb. Haemost. 78: 117-120, 1997.
44. McNiel E.A., Ogilvie G.K., Fettman M.J., Salman M.D.: Platelet hyperfunction in dogs with malignancies. J. Vet. Intern. Med. 11: 178-182, 1997.
45. International consensus statement. Prevention of venous thromboembolism. Int. Angiol. 16: 3-38, 1997.
46. Laing E.J., Carter R.F.: Acute tumor lysis syndrome following treatment of canine lymphoma. J. Am. Anim. Hosp. Assoc. 24: 691-696, 1988.
47. Brooks D.G.: Acute tumor lysis syndrome in dogs. Comp. Cont. Ed. 17: 1103-1106, 1995.
48. Vail D.M., Mac Ewen E.G., Young K.M.: Canine lymphoma and lymphoid leukemias. In: Withrow S.J., Mac Ewen G.E. Small Animal Clinical Oncology. 3rd Edition. Philadelphia, W. B. Saunders Company, 2001: 558-590.
49. Orlowski S., Mir L.M.: Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta 1154: 51-63, 1993.
50. Zuckerman J.E., Raffin T.A., Brown J.M., Newman R.A., Etiz B.B., Sikic B.I.: In vitro selection and characterization of a bleomycin-resistant subline of B 16 melanoma. Cancer Res. 46: 1748-53, 1986.
51. Epstein E.: Intralesional bleomycin and Raynaud's phenomenon. J. Am. Acad. Dermatol. 24: 785-786, 1991.
52. Gregg L.J.: Intralesional bleomycin and Raynaud's phenomenon. J. Am. Acad. Dermatol. 26: 279-280, 1992.
53. Rajan R., Gafni A., Levine M., Hirsh J., Gent M.: Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation. J. Clin. Oncol. 13: 42-46, 1995.
54. Levine M., Hirsh J., Gent M., Arnold A., Warr D., Falanga A., Samosh M., Bramwell V., Pritchard K.I., Stewart D., et al.: Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343: 886-889, 1994.
55. Abdul Hamied T.A., Turk J.L.: Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo. Cancer Immunol. Immunother. 25: 245-249, 1987.
56. Kafman D., Chabner B.A.: Clinical strategies for cancer treatment. In: Chabner B.A., Longo D.L. Cancer chemotherapy and biotherapy. 2nd Edition. Philadelphia, Lippincott-Raven, 1996: 14-15.
57. Mir L.M.: Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 53: 1-10, 2001.